Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

Patients with relapsed/refractory (R/R) transformed diffused large B cell lymphoma (tDLBCL) have a poor prognosis and a low survival rate. In addition, no standard therapy has yet been established for R/R tDLBCL. Herein we presented a single case of a patient with R/R tDLBCL who was successfully tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao, Zhang, Wei, Zhou, Daobin, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606549/
https://www.ncbi.nlm.nih.gov/pubmed/34820328
http://dx.doi.org/10.3389/fonc.2021.757403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606549/
https://www.ncbi.nlm.nih.gov/pubmed/34820328
http://dx.doi.org/10.3389/fonc.2021.757403

Ejemplares similares